Wikidata

(Q100788545)

English

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

clinical trial

In more languages

Statements

title
An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies (English)
0 references
sponsor
Bayer
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belarus
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Colombia
0 references
Estonia
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Italy
0 references
Japan
0 references
Latvia
0 references
Lithuania
0 references
Peru
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Taiwan
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
30 October 2020
0 references
end time
18 October 2024
0 references
number of participants
500
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q100788545&oldid=2136228496"